[1]Corbett EL, Watt CJ, Walker N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med, 2003,163(9):1009-1021. [2]Flynn JL. Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinb),2004,84(1/2):93-101. [3]Darrah PA, Patel DT, De Luca PM, et al. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med, 2007,13(7):843-850. [4]Harari A, Rozot V, Enders EB, et al. Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease. Nat Med,2011,17(3):372-376. [5]Agger EM, Cassidy JP, Brady J, et al. Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines; immunity, pathology and protection. Immunology, 2008,124(2):175-185. [6]Turner J, Gonzalez-Juarrero M, Ellis DL, et al. In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J Immunol,2002,169(11):6343-6351. [7]Sacco R, Hagen M, Sandor M,et al. Established T(H1) gra-nulomatous responses induced by active Mycobacterium avium infection switch to T(H2) following challenge with Schistosoma mansoni. Clin Immunol,2002,104(3):274-281. [8]Ordway DJ, Costa L, Martins M,et al. Increased Interleukin-4 production by CD8 and gammadelta T cells in health-care workers is associated with the subsequent development of active tuberculosis. J Infect Dis,2004,190(4):756-766. [9]Forbes EK, Sander C, Ronan EO, et al. Multifunctional, high-level cytokine-producing Th1 cells in the lung, but not spleen, correlate with protection against Mycobacterium tuberculosis aerosol challenge in mice. J Immunol, 2008,181(7):4955-4964. [10]Kannanganat S, Ibegbu C, Chennareddi L, et al. Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells. J Virol,2007,81(16):8468-8476. |